1 Product identity
Ingredient risk
Contains restricted ingredients

Raw Shilajit Complex

Brandeleva NUTRITION→Other Combinations Capsule 8 ingredients 1 banned 1 caution DSLD #323097
Net contents: 210 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2025-03-25
2 Ingredients (8)
IngredientGroupSafety
Shilajit Extract, RawShilajitLimited Evidence
Male Vitality BlendBlend (Combination)—
MacaMacaUse with Caution
TribulusTribulusLimited Evidence
AshwagandhaAshwagandhaBanned in ≥1 country
Panax ginsengGinsengConditionally Safe
Black Pepper, PowderBlack Pepper—
MethylcelluloseMethyl cellulose—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
Ashwagandha  🇩🇰 🇧🇪 🇪🇺 — Banned April 2023 following DTU risk assessment. All products withdrawn.
⚠️ Use with caution — restricted in some markets
Maca  🇺🇸 🇰🇷 🇪🇺 — ood. Dietary supplement [1]. || European Union :: Novel food ingredient [1]. || South Korea :: Dietary supplement. || Ma
3 Safety cross-reference
Shilajit — Limited Evidence
⚠ Heavy metal contamination risk if unpurified
⚠ May increase iron levels
Maca — Use with Caution
⚠ Goitrogenic
⚠ Hormonal effects
Tribulus — Limited Evidence
⚠ Liver and kidney toxicity case reports
⚠ Hormonal claims poorly supported
Ashwagandha — Banned in ≥1 country
⚠ Thyroid stimulation
⚠ HEPATOTOXICITY (rare but serious case reports)
Panax Ginseng — Conditionally Safe
⚠ Insomnia
⚠ Estrogenic effects
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID323097
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2025-03-25
6 More from eleva NUTRITION
View eleva NUTRITION Safety Scorecard → 2 products
Citrus Bergamot Complex 1,000 mg
7 Cite this page
Vancouver
Pkhakadze G. Raw Shilajit Complex — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 25]. Available from: https://supplement.ge/products/raw-shilajit-complex-323097/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG